Now showing items 1-1 of 1

    • Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21. 

      Müller, LME; Holmes, M; Michael, JL; Scott, GB; West, EJ; Scott, KJ; Parrish, C; Hall, K; Stäble, S; Jennings, VA; Cullen, M; McConnell, S; Langton, C; Tidswell, EL; Shafren, D; Samson, A; Harrington, KJ; Pandha, H; Ralph, C; Kelly, RJ; Cook, G; Melcher, AA; Errington-Mais, F (2019-07)
      BACKGROUND:The oncolytic virus, coxsackievirus A21 (CVA21), has shown promise as a single agent in several clinical trials and is now being tested in combination with immune checkpoint blockade. Combination therapies offer ...